Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Amortization of Deferred Charges (2019 - 2023)

Harmony Biosciences Holdings (HRMY) has disclosed Amortization of Deferred Charges for 5 consecutive years, with $424000.0 as the latest value for Q2 2023.

  • Quarterly Amortization of Deferred Charges rose 3.16% to $424000.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Jun 2023, down 1.18% year-over-year, with the annual reading at $1.7 million for FY2022, 25.69% down from the prior year.
  • Amortization of Deferred Charges hit $424000.0 in Q2 2023 for Harmony Biosciences Holdings, up from $416000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $1.4 million in Q4 2020 to a low of -$901000.0 in Q4 2019.
  • Historically, Amortization of Deferred Charges has averaged $402312.5 across 5 years, with a median of $417000.0 in 2021.
  • Biggest five-year swings in Amortization of Deferred Charges: skyrocketed 254.5% in 2020 and later plummeted 69.97% in 2021.
  • Year by year, Amortization of Deferred Charges stood at -$901000.0 in 2019, then surged by 254.5% to $1.4 million in 2020, then tumbled by 69.97% to $418000.0 in 2021, then rose by 0.96% to $422000.0 in 2022, then rose by 0.47% to $424000.0 in 2023.
  • Business Quant data shows Amortization of Deferred Charges for HRMY at $424000.0 in Q2 2023, $416000.0 in Q1 2023, and $422000.0 in Q4 2022.